Biosimilar Tipping Point: Five Questions For Henlius CEO

 
• By Brian Yang
  
China flag with arrow graph going up showing strong economy and shares rise. Profit and success. Isolated vector illustration.
CEO Of China's Henlius Talks Biosimilar Development And Emerging Markets Strategy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia